Back

In-hospital bleeding and utility of a maintenance dose of prasugrel 2.5 mg in high bleeding risk patients with acute coronary syndrome

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Pharmacologic treatment of acute coronary syndromes Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Masanobu Ohya

Kurashiki Central Hospital, Kurashiki (Japan)

9 More presentations in this session

Presentation thumbnail
Pleiotropic effects of high-dose atorvastatin therapy in patients with ST-segment elevation myocardial infarction
Associate Professor L. Salyamova (Penza, RU)
Abstract Slides
Presentation thumbnail
Smoking and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: the TROPICAL-ACS smoking substudy
Doctor M. Orban (Munich, DE)
Abstract Slides
Presentation thumbnail
Effect of cyclosporine on lymphocyte kinetics and left ventricular remodelling in patients with acute myocardial infarction
Doctor A. Mohammed (Newcastle-Upon-Tyne, GB)
Abstract
Presentation thumbnail
Myocardial regeneration strategy using wharton's jelly multipotent stem cells as an 'unlimited' therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial.
Doctor E. Kwiecien (Krakow, PL)
Abstract Slides
Presentation thumbnail
Assessment of ankle-brachial index to predict in-hospital bleeding complication and optimal duration of dual antiplatelet therapy in patients with acute coronary syndrome
Doctor T. Nakahashi (Kanazawa, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Pharmacologic treatment of acute coronary syndromes

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources